BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1772273)

  • 1. [Clinical and pathological characteristics of carcinoma of the kidney: computerized analysis].
    Garofalo F; Messina S; de Santis P; Nanni G; Tomaselli V; Garofalo M
    Arch Esp Urol; 1991; 44(6):691-5. PubMed ID: 1772273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small renal tumors: correlation of clinical and pathological features with tumor size.
    Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
    J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma.
    Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M
    Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
    Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
    J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
    Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A
    J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
    Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.